On the occasion of World Thyroid Day, we would like to highlight our participation at last week’s BioStock Global Forum in Lund, where we presented our work on developing a next-generation modified-release T3 therapy for hypothyroidism.

The event brought together investors, companies, and key stakeholders from across the life science sector, creating a valuable platform for insightful discussions and meaningful exchanges.

We appreciate the strong engagement and look forward to continuing the dialogue with the life science community.